StoxSyngene International vs Vijaya Diagnostic Centre: share price & financials comparison
NSE: SYNGENE vs VIJAYA · Healthcare · as of 06 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Syngene International vs Vijaya Diagnostic Centre at a glance
Syngene International (SYNGENE) has a market capitalisation of ₹16,846 Cr, against ₹15,126 Cr for Vijaya Diagnostic Centre (VIJAYA). Over the past year Vijaya Diagnostic Centre has returned +45.8%, compared with -36.7% for Syngene International. On valuation, Vijaya Diagnostic Centre trades at a lower P/E of 74.3 versus 441.0. Vijaya Diagnostic Centre earns a higher return on equity (19.3% vs 0.8%). Syngene International comes out ahead on valuation. Vijaya Diagnostic Centre comes out ahead on size, profitability, growth, momentum and technicals. Across the scored metrics below, Syngene International leads on 3 and Vijaya Diagnostic Centre on 12. On StoxGud's 10-point checklist, Syngene International scores 3/10 and Vijaya Diagnostic Centre scores 9/10.
| Metric | Syngene International | Vijaya Diagnostic Centre |
|---|---|---|
| Size | ||
| Market cap | ₹16,846 Cr | ₹15,126 Cr |
| Revenue (latest FY) | ₹3,739 Cr | ₹814 Cr |
| Net profit (latest FY) | ₹0 Cr | ₹173 Cr |
| Valuation | ||
| P/E | 441.0 | 74.3 |
| P/B | 3.47 | 14.31 |
| Dividend yield | 0.30% | 0.14% |
| Profitability | ||
| Return on equity | 0.8% | 19.3% |
| Net profit margin | 1.1% | 22.4% |
| Operating margin | 21.3% | 43.1% |
| Growth | ||
| Revenue growth (YoY) | -8.6% | +26.7% |
| Net profit growth (YoY) | — | +37.4% |
| Revenue CAGR (multi-year) | +11.3% | +15.2% |
| Financial health | ||
| Debt to equity | 0.01 | 0.00 |
| Momentum | ||
| 1-month return | +15.8% | +0.4% |
| 1-year return | -36.7% | +45.8% |
| 3-year CAGR | -16.4% | +35.9% |
| 5-year CAGR | -5.3% | +21.1% |
| 10-year CAGR | +4.3% | — |
| Distance from 52W high | -37.1% | -6.5% |
| Technicals | ||
| RSI (14) | 60 | 67 |
| Price vs 200-day avg | -1.8% | +18.0% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Syngene International | Vijaya Diagnostic Centre |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✗ | ✓ |
| 50-day average above 200-day (uptrend) | ✗ | ✓ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✗ | ✓ |
| Return on equity above 15% | ✗ | ✓ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✗ | ✓ |
| Net profit margin above 10% | ✗ | ✓ |
| P/E below industry median | ✗ | ✗ |
| Score | 3/10 | 9/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Syngene International or Vijaya Diagnostic Centre?
Syngene International has a market cap of ₹16,846 Cr and Vijaya Diagnostic Centre has a market cap of ₹15,126 Cr as of 06 Nov 2026.
Which has a lower P/E, Syngene International or Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre has the lower P/E: Syngene International trades at 441.0 and Vijaya Diagnostic Centre at 74.3.
Which gave better returns in the last year, Syngene International or Vijaya Diagnostic Centre?
Vijaya Diagnostic Centre did better: Syngene International returned -36.7% and Vijaya Diagnostic Centre returned +45.8% over one year.
Is Syngene International or Vijaya Diagnostic Centre a better buy?
StoxGud does not give buy or sell recommendations. On our rules-based checklist Syngene International scores 3/10 and Vijaya Diagnostic Centre scores 9/10; compare valuation, profitability, growth and momentum above and consult a SEBI-registered adviser.